• Login
    View Item 
    •   UCUDIR Home
    • Research Papers and Publications
    • School of Medicine
    • View Item
    •   UCUDIR Home
    • Research Papers and Publications
    • School of Medicine
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda

    Thumbnail
    View/Open
    Wanyenze et al._Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda_2017.pdf (1.244Mb)
    Date
    2017-10
    Author
    Wanyenze, Rhoda K.
    Bwanika, John Baptist
    Beyeza-Kashesya, Jolly
    Mugerwa, Shaban
    Arinaitwe, Jim
    Matovu, Joseph K. B.
    Gwokyalya, Violet
    Kasozi, Dickson
    Bukenya, Justine
    Makumb, Fred
    Metadata
    Show full item record
    Abstract
    Objective: This study assessed uptake and correlates of cervical screening among HIV-infected women in care in Uganda. Methods: A nationally representative cross-sectional survey of HIV-infected women in care was conducted from August to November 2016. Structured interviews were conducted with 5198 women aged 15–49 years, from 245 HIV clinics. Knowledge and uptake of cervical screening and human papillomavirus (HPV) vaccination were determined. Correlates of cervical screening were assessed with modified Poisson regression to obtain prevalence ratios (PRs) using Stata version 12.0. Results: Overall, 94.0% (n = 4858) had ever heard of cervical screening and 66% (n = 3732) knew a screening site. However, 47.4% (n = 2302) did not know the schedule for screening and 50% (n = 2409) did not know the symptoms of cervical cancer. One-third (33.7%; n = 1719) rated their risk of cervical cancer as low. Uptake of screening was 30.3% (n = 1561). Women who had never been screened cited lack of information (29.6%; n = 1059) and no time (25.5%; n = 913) as the main reasons. Increased likelihood of screening was associated with receipt of HIV care at a level II health center [adj. PR 1.89, 95% confidence interval (CI) 1.29–2.76] and private facilities (adj. PR 1.68, 95% CI 1.16–3.21), knowledge of cervical screening (adj. PR 2.19, 95% CI 1.78–2.70), where to go for screening (adj. PR 6.47, 95% CI 3.69–11.36), and low perception of risk (adj. PR 1.52, 95% CI 1.14–2.03). HPV vaccination was 2%. Conclusions: Cervical screening and HPV vaccination uptake were very low among HIV-infected women in care in Uganda. Improved knowledge of cervical screening schedules and sites, and addressing fears and risk perception may increase uptake of cervical screening in this vulnerable population.
    Use this URI to cite this item:
    https://hdl.handle.net/20.500.11951/348
    Collections
    • School of Medicine [158]

    UCUDIR copyright © 2017-2019  UCU Library |  Search Library Catalogue
    Contact Us | Send Feedback
     
    Atmire NV
     

     

    Browse

    All of UCUDIRCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    UCUDIR copyright © 2017-2019  UCU Library |  Search Library Catalogue
    Contact Us | Send Feedback
     
    Atmire NV